1.A Case of Aldosteronoma Complicated with Hyperthyroidism.
Yeo Joo KIM ; Mi Rim KIM ; Moon Seok NAM ; Hyo Young MIN ; Sung Ryol KWON ; Sung Wook CHO ; Young Ub CHO ; Yong Sung KIM
Journal of Korean Society of Endocrinology 1998;13(3):480-488
Primary aldosteronism is characterized by hypokalemic metabolic alkalosis, low plasma renin activity, elevated plasma aldosterone level and can be suspected in the patients with hypertension and unexplained hypokalemia. Small adrenal cortical adenomas are responsible for this syndrome in most cases. The incidence of thyrotoxic periodic paralysis ranges from 1.9 to 6.2 % in Japan. Thyrotoxic periodic paralysis usually subsides following treatment of hyperthyroidism and has good prognosis. A 56 year-old man presented with hyperthyroidism, hypertension and recurrent hypokalemia. During the treatment of hyperthyroidism, he repeatedly experienced weakness of both lower extremities. Hormonal evaluation was performed and he was found to have a 2*2*1.5 cm sized right adrenal tumor by abdominal computerized topography(CT). After right adrenalectomy, hypokalemic periodic paralysis was improved. Both thyroid and adrenal function should be comprehensively investigated in periodic paralysis. In conclusion, physicians must be aware of the possibility of primary aldosteronism in hyperthyroid patients with hypokalemic periodic paralysis. We report a case of aldosteronoma complicated with hyperthyroidism and literatures are reviewed.
Adrenalectomy
;
Adrenocortical Adenoma
;
Aldosterone
;
Alkalosis
;
Humans
;
Hyperaldosteronism
;
Hypertension
;
Hyperthyroidism*
;
Hypokalemia
;
Hypokalemic Periodic Paralysis
;
Incidence
;
Japan
;
Lower Extremity
;
Middle Aged
;
Paralysis
;
Plasma
;
Prognosis
;
Renin
;
Thyroid Gland
2.EEG Revealed That Fragrances Positively Affect Menopausal Symptoms in Mid-life Women
Sun Ae MOON ; Jis ub BAE ; Kwang su KIM ; Si Young CHO ; Gu sang KWON ; Ran LEE ; Seung Ho KO ; Soy eon LIM ; Che il MOON
Experimental Neurobiology 2020;29(5):389-401
During mid-life, women experienced not only physical but also neurological transition. Because of this, many women suffer from physiological and/or psychological menopausal symptoms. Although hormone therapy (HT) was broadly used to alleviate menopausal symptoms, HT showed inconsistent effects in case of psychological symptoms. Moreover, mid-life women’s brains have distinct characteristics than in other periods of life, it is needed to study psychological symptoms in shifted brain network of mid-life women. As an alternative, inhalation of fragrances may alleviate psychological menopausal symptoms. To characterize the alleviation mechanism by fragrances, we tested the effect of fragrances on menopausal symptoms using electroencephalographic (EEG) methods. We hypothesized that fragrance could restore mid-life women’s brain response to stressful situations. We tested six fragrance conditions, including no-odor condition (solvent only) in twenty-eight mid-life women (49.75 years±3.49).Our results showed that fragrances increased alpha power and decreased β/α ratio depending on the severity of menopausal symptoms in a stressful situation. Our study would be helpful in psychological menopausal symptom alleviation as well as fragrance screening for well-being in mid-life.